VIPR1 anticorps (C-Term)
Aperçu rapide pour VIPR1 anticorps (C-Term) (ABIN1881994)
Antigène
Voir toutes VIPR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 305-334, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This VIPR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 305-334 amino acids from the C-terminal region of human VIPR1.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
-
: "Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1." dans: Cancer investigation, Vol. 28, Issue 5, pp. 487-94, (2010) (PubMed).
: "Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients." dans: Peptides, Vol. 31, Issue 4, pp. 603-8, (2010) (PubMed).
-
-
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
-
Autre désignation
- VIPR1
-
Sujet
- This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase.
-
Poids moléculaire
- 51547
-
NCBI Accession
- NP_001238811, NP_001238812, NP_001238813, NP_001238814, NP_004615
-
UniProt
- P32241
Antigène
-